SGN-LIV1A

SGN-LIV1A Uses, Dosage, Side Effects, Food Interaction and all others data.

SGN-LIV1A is under investigation in clinical trial NCT01969643 (A Safety Study of SGN-LIV1A in Breast Cancer Patients).

Trade Name SGN-LIV1A
Generic Ladiratuzumab vedotin
Ladiratuzumab vedotin Other Names Ladiratuzumab vedotin, SGN-LIV1A
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
SGN-LIV1A
SGN-LIV1A

Innovators Monograph

You find simplified version here SGN-LIV1A


*** Taking medicines without doctor's advice can cause long-term problems.
Share